CONFIDENTIAL TREATMENT LICENSE AGREEMENTLicense Agreement • August 6th, 2004 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (this “Agreement”), effective as of June 2, 2004 (the “Effective Date”), is between CUBIST PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware (together with its Affiliates referred to herein as “CUBIST”) and XTL BIOPHARMACEUTICALS LTD., a corporation organized and existing under the laws of Israel (together with its Affiliates referred to herein as “XTL”). XTL and CUBIST are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties.”
CONFIDENTIAL TREATMENT Amendment #1 to the License Agreement dated October 2, 2003 made by and between Chiron Healthcare Ireland, Ltd. and Cubist Pharmaceuticals, Inc.Confidential Treatment • August 6th, 2004 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
Incorporating the terms and conditions of the License Agreement effective as of October 2, 2003 made by and between Chiron Healthcare Ireland, Ltd. and Cubist Pharmaceuticals, Inc. (hereinafter referred to as the “Agreement”), the Agreement is amended, effective as of April 1, 2004, as set forth herein. Capitalized terms in this Amendment #1 shall have the same meaning as in the Agreement.
